Date |
Presented by |
Title |
NO |
2020/10/20 |
Dr. Latifi |
1 |
|
2020/11/11 |
Dr. Didehvar |
Clinical practice guidance for hepatplogy and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations |
2 |
2020/11/18 |
Dr. Samnipour |
Immunomodulation and regeneration of dental pulp stem cells: a potential therapy to treat Cronavirus disease 2019 |
3 |
2020/11/29 |
Dr. Namdar |
Effect of different human tissue processing techniques on SARS-CoV-2 inactivation |
4 |
2021/02/18 |
Miss Salasi |
Hepatogenesis: origin and fates of hepatic cells |
5 |
2021/02/22 |
Dr. Derakhshan |
Trans differentiation of hepatic cells from different origins |
6 |
2021/03/16 |
Dr. Namdari |
Production of liver organoids from human pluripotent stem cells & disease modeling |
7 |
2021/04/08 |
Miss Karami |
Application of hPSC-derived hepatic cell leanages and liver organoids& regenerative medicine |
8 |
2021/04/15 |
Miss Norouzi |
Human organoids market, liver model/ clinical trials & patents |
9 |